nodes	percent_of_prediction	percent_of_DWPC	metapath
Cocaine—CYP3A4—bone cancer	0.871	1	CbGaD
Cocaine—SLC22A2—Cisplatin—bone cancer	0.0482	0.645	CbGbCtD
Cocaine—CYP2C9—Cisplatin—bone cancer	0.0132	0.177	CbGbCtD
Cocaine—CYP2D6—Doxorubicin—bone cancer	0.0081	0.108	CbGbCtD
Cocaine—CYP3A4—Doxorubicin—bone cancer	0.00515	0.069	CbGbCtD
Cocaine—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000477	0.00884	CbGpPWpGaD
Cocaine—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000475	0.0088	CbGpPWpGaD
Cocaine—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000471	0.00873	CbGpPWpGaD
Cocaine—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.00044	0.00816	CbGpPWpGaD
Cocaine—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000437	0.00809	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000426	0.0079	CbGpPWpGaD
Cocaine—SCN5A—Cardiac Progenitor Differentiation—KIT—bone cancer	0.000424	0.00787	CbGpPWpGaD
Cocaine—CHRM2—GPCRs, Other—GRM1—bone cancer	0.000417	0.00772	CbGpPWpGaD
Cocaine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000399	0.0074	CbGpPWpGaD
Cocaine—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000394	0.0073	CbGpPWpGaD
Cocaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000362	0.0067	CbGpPWpGaD
Cocaine—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000336	0.00623	CbGpPWpGaD
Cocaine—CHRM1—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000328	0.00608	CbGpPWpGaD
Cocaine—CHRM2—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000324	0.006	CbGpPWpGaD
Cocaine—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000323	0.006	CbGpPWpGaD
Cocaine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00032	0.00594	CbGpPWpGaD
Cocaine—SCN11A—L1CAM interactions—EGFR—bone cancer	0.000308	0.00571	CbGpPWpGaD
Cocaine—CHRM2—GPCRs, Other—SMO—bone cancer	0.000294	0.00544	CbGpPWpGaD
Cocaine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000288	0.00535	CbGpPWpGaD
Cocaine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000288	0.00534	CbGpPWpGaD
Cocaine—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000285	0.00528	CbGpPWpGaD
Cocaine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00025	0.00463	CbGpPWpGaD
Cocaine—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000247	0.00457	CbGpPWpGaD
Cocaine—SLC6A4—NRF2 pathway—GSTP1—bone cancer	0.000241	0.00447	CbGpPWpGaD
Cocaine—SLC6A4—NRF2 pathway—TGFBR2—bone cancer	0.000241	0.00447	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—GNA11—bone cancer	0.000241	0.00447	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—EZH2—bone cancer	0.00024	0.00445	CbGpPWpGaD
Cocaine—CHRM1—G alpha (q) signalling events—GRM1—bone cancer	0.000237	0.0044	CbGpPWpGaD
Cocaine—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000234	0.00433	CbGpPWpGaD
Cocaine—SCN11A—Axon guidance—MET—bone cancer	0.00023	0.00426	CbGpPWpGaD
Cocaine—CHRM2—G alpha (i) signalling events—RGS1—bone cancer	0.000225	0.00417	CbGpPWpGaD
Cocaine—CHRM2—G alpha (i) signalling events—GRM4—bone cancer	0.000225	0.00417	CbGpPWpGaD
Cocaine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000212	0.00393	CbGpPWpGaD
Cocaine—SLC6A2—NRF2 pathway—GSTP1—bone cancer	0.000208	0.00385	CbGpPWpGaD
Cocaine—SLC6A2—NRF2 pathway—TGFBR2—bone cancer	0.000208	0.00385	CbGpPWpGaD
Cocaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000205	0.0038	CbGpPWpGaD
Cocaine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000203	0.00377	CbGpPWpGaD
Cocaine—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000203	0.00375	CbGpPWpGaD
Cocaine—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000202	0.00375	CbGpPWpGaD
Cocaine—SCN10A—L1CAM interactions—EGFR—bone cancer	0.000202	0.00374	CbGpPWpGaD
Cocaine—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000201	0.00372	CbGpPWpGaD
Cocaine—SCN11A—Axon guidance—MMP2—bone cancer	0.000192	0.00355	CbGpPWpGaD
Cocaine—SLC6A3—NRF2 pathway—TGFBR2—bone cancer	0.000184	0.00341	CbGpPWpGaD
Cocaine—SLC6A3—NRF2 pathway—GSTP1—bone cancer	0.000184	0.00341	CbGpPWpGaD
Cocaine—CHRM1—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000183	0.0034	CbGpPWpGaD
Cocaine—CHRM2—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000181	0.00335	CbGpPWpGaD
Cocaine—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000172	0.00318	CbGpPWpGaD
Cocaine—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000169	0.00314	CbGpPWpGaD
Cocaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000166	0.00308	CbGpPWpGaD
Cocaine—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000165	0.00306	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—MET—bone cancer	0.000164	0.00304	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—CDK4—bone cancer	0.000164	0.00304	CbGpPWpGaD
Cocaine—SLC6A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000163	0.00302	CbGpPWpGaD
Cocaine—CHRM1—G alpha (q) signalling events—GNA11—bone cancer	0.000153	0.00283	CbGpPWpGaD
Cocaine—SCN10A—Axon guidance—MET—bone cancer	0.000151	0.00279	CbGpPWpGaD
Cocaine—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000147	0.00272	CbGpPWpGaD
Cocaine—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000145	0.00269	CbGpPWpGaD
Cocaine—SLC6A3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000145	0.00268	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—GNA11—bone cancer	0.000144	0.00267	CbGpPWpGaD
Cocaine—SCN11A—Axon guidance—MMP9—bone cancer	0.000144	0.00267	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—EZH2—bone cancer	0.000144	0.00266	CbGpPWpGaD
Cocaine—SCN5A—L1CAM interactions—EGFR—bone cancer	0.000142	0.00263	CbGpPWpGaD
Cocaine—SLC6A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000141	0.00261	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—GRM4—bone cancer	0.000138	0.00256	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—MMP2—bone cancer	0.000137	0.00254	CbGpPWpGaD
Cocaine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000137	0.00253	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—GRM4—bone cancer	0.000136	0.00252	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—CDK4—bone cancer	0.000135	0.00251	CbGpPWpGaD
Cocaine—SLC22A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000132	0.00244	CbGpPWpGaD
Cocaine—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000128	0.00237	CbGpPWpGaD
Cocaine—SCN10A—Axon guidance—MMP2—bone cancer	0.000126	0.00233	CbGpPWpGaD
Cocaine—SLC6A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000125	0.00231	CbGpPWpGaD
Cocaine—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.000124	0.0023	CbGpPWpGaD
Cocaine—SCN5A—SIDS Susceptibility Pathways—JUN—bone cancer	0.000123	0.00227	CbGpPWpGaD
Cocaine—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000122	0.00227	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—GRM1—bone cancer	0.00012	0.00222	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—GRM1—bone cancer	0.000118	0.00219	CbGpPWpGaD
Cocaine—SCN11A—Axon guidance—EGFR—bone cancer	0.000116	0.00216	CbGpPWpGaD
Cocaine—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000114	0.0021	CbGpPWpGaD
Cocaine—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000108	0.00199	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—CDK4—bone cancer	0.000108	0.00199	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—MET—bone cancer	0.000108	0.00199	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—JUN—bone cancer	0.000107	0.00198	CbGpPWpGaD
Cocaine—CYP3A5—Biological oxidations—GSTP1—bone cancer	0.000106	0.00197	CbGpPWpGaD
Cocaine—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000106	0.00197	CbGpPWpGaD
Cocaine—SCN5A—Axon guidance—MET—bone cancer	0.000106	0.00196	CbGpPWpGaD
Cocaine—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	0.000105	0.00194	CbGpPWpGaD
Cocaine—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000104	0.00193	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—NDUFA12—bone cancer	0.000103	0.00191	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—MMP9—bone cancer	0.000103	0.00191	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—NDUFA12—bone cancer	0.000103	0.00191	CbGpPWpGaD
Cocaine—SCN10A—Axon guidance—MMP9—bone cancer	9.45e-05	0.00175	CbGpPWpGaD
Cocaine—CYP2C8—Biological oxidations—GSTP1—bone cancer	9.2e-05	0.00171	CbGpPWpGaD
Cocaine—SLC6A3—Transmission across Chemical Synapses—BRAF—bone cancer	9.17e-05	0.0017	CbGpPWpGaD
Cocaine—CHRM1—Regulation of Actin Cytoskeleton—BRAF—bone cancer	9.12e-05	0.00169	CbGpPWpGaD
Cocaine—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	9.07e-05	0.00168	CbGpPWpGaD
Cocaine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—bone cancer	9e-05	0.00167	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—MMP2—bone cancer	8.97e-05	0.00166	CbGpPWpGaD
Cocaine—SCN5A—Axon guidance—MMP2—bone cancer	8.84e-05	0.00164	CbGpPWpGaD
Cocaine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	8.83e-05	0.00164	CbGpPWpGaD
Cocaine—CYP2C9—Biological oxidations—CYP3A4—bone cancer	8.76e-05	0.00162	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—JUN—bone cancer	8.73e-05	0.00162	CbGpPWpGaD
Cocaine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	8.71e-05	0.00161	CbGpPWpGaD
Cocaine—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	8.64e-05	0.0016	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—NT5C3A—bone cancer	8.53e-05	0.00158	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—NT5C3A—bone cancer	8.52e-05	0.00158	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—SMO—bone cancer	8.43e-05	0.00156	CbGpPWpGaD
Cocaine—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	8.34e-05	0.00155	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—SMO—bone cancer	8.32e-05	0.00154	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—EGFR—bone cancer	8.31e-05	0.00154	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—CDK4—bone cancer	8.11e-05	0.0015	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—GRM4—bone cancer	7.8e-05	0.00145	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—RGS1—bone cancer	7.8e-05	0.00145	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—GRM4—bone cancer	7.7e-05	0.00143	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—RGS1—bone cancer	7.7e-05	0.00143	CbGpPWpGaD
Cocaine—SLC6A3—Transmission across Chemical Synapses—MDM2—bone cancer	7.68e-05	0.00142	CbGpPWpGaD
Cocaine—SCN10A—Axon guidance—EGFR—bone cancer	7.63e-05	0.00142	CbGpPWpGaD
Cocaine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	7.62e-05	0.00141	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—MET—bone cancer	7.56e-05	0.0014	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—CDK4—bone cancer	7.56e-05	0.0014	CbGpPWpGaD
Cocaine—CYP2D6—Biological oxidations—GSTP1—bone cancer	7.55e-05	0.0014	CbGpPWpGaD
Cocaine—CYP2C9—Biological oxidations—GSTP1—bone cancer	7.49e-05	0.00139	CbGpPWpGaD
Cocaine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	7.45e-05	0.00138	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—NDUFA12—bone cancer	7.45e-05	0.00138	CbGpPWpGaD
Cocaine—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	7.39e-05	0.00137	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—GRM4—bone cancer	7.08e-05	0.00131	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—RGS1—bone cancer	7.08e-05	0.00131	CbGpPWpGaD
Cocaine—SLC6A3—Neuronal System—BRAF—bone cancer	7.02e-05	0.0013	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—GRM4—bone cancer	6.99e-05	0.0013	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—RGS1—bone cancer	6.99e-05	0.0013	CbGpPWpGaD
Cocaine—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	6.99e-05	0.0013	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—GRM1—bone cancer	6.76e-05	0.00125	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—MMP9—bone cancer	6.74e-05	0.00125	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—GRM1—bone cancer	6.67e-05	0.00124	CbGpPWpGaD
Cocaine—SCN5A—Axon guidance—MMP9—bone cancer	6.64e-05	0.00123	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—NDUFA12—bone cancer	6.45e-05	0.0012	CbGpPWpGaD
Cocaine—SLC22A2—Neuronal System—BRAF—bone cancer	6.39e-05	0.00118	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—JUN—bone cancer	6.32e-05	0.00117	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—MMP2—bone cancer	6.31e-05	0.00117	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—NT5C3A—bone cancer	6.17e-05	0.00114	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—GRM1—bone cancer	6.14e-05	0.00114	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—GRM1—bone cancer	6.06e-05	0.00112	CbGpPWpGaD
Cocaine—SLC6A3—Neuronal System—MDM2—bone cancer	5.89e-05	0.00109	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—TP53—bone cancer	5.76e-05	0.00107	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—EGFR—bone cancer	5.45e-05	0.00101	CbGpPWpGaD
Cocaine—SCN5A—Axon guidance—EGFR—bone cancer	5.37e-05	0.000995	CbGpPWpGaD
Cocaine—SLC22A2—Neuronal System—MDM2—bone cancer	5.35e-05	0.000992	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—NT5C3A—bone cancer	5.34e-05	0.00099	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—NDUFA12—bone cancer	5.29e-05	0.000981	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—NDUFA12—bone cancer	5.25e-05	0.000973	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—JUN—bone cancer	5.23e-05	0.000969	CbGpPWpGaD
Cocaine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—bone cancer	5.22e-05	0.000968	CbGpPWpGaD
Cocaine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—bone cancer	5.15e-05	0.000955	CbGpPWpGaD
Cocaine—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.94e-05	0.000915	CbGpPWpGaD
Cocaine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.87e-05	0.000903	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—MMP9—bone cancer	4.74e-05	0.000878	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—NT5C3A—bone cancer	4.39e-05	0.000813	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—GNA11—bone cancer	4.36e-05	0.000808	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—NT5C3A—bone cancer	4.35e-05	0.000806	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—SMO—bone cancer	4.33e-05	0.000802	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—GNA11—bone cancer	4.3e-05	0.000797	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—SMO—bone cancer	4.27e-05	0.000791	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—RGS1—bone cancer	4.18e-05	0.000775	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—GRM4—bone cancer	4.18e-05	0.000775	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—GRM4—bone cancer	4.13e-05	0.000765	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—RGS1—bone cancer	4.13e-05	0.000765	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—GNA11—bone cancer	3.96e-05	0.000733	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—IL3—bone cancer	3.95e-05	0.000732	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—GNA11—bone cancer	3.91e-05	0.000724	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—IL3—bone cancer	3.9e-05	0.000723	CbGpPWpGaD
Cocaine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	3.89e-05	0.000722	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—EGFR—bone cancer	3.83e-05	0.00071	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—ENO2—bone cancer	3.74e-05	0.000693	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—ENO2—bone cancer	3.73e-05	0.000692	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—GRM1—bone cancer	3.63e-05	0.000672	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—IL3—bone cancer	3.59e-05	0.000665	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—GRM1—bone cancer	3.58e-05	0.000664	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—IL3—bone cancer	3.54e-05	0.000656	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—DHFR—bone cancer	3.47e-05	0.000643	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—DHFR—bone cancer	3.46e-05	0.000642	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—NDUFA12—bone cancer	3.46e-05	0.000642	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—TP53—bone cancer	3.45e-05	0.000639	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—GNA11—bone cancer	3.24e-05	0.000601	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—GNA11—bone cancer	3.24e-05	0.0006	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—CYP3A4—bone cancer	2.94e-05	0.000545	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—CYP3A4—bone cancer	2.93e-05	0.000544	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—NT5C3A—bone cancer	2.87e-05	0.000532	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—ENO2—bone cancer	2.7e-05	0.000501	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—SMO—bone cancer	2.56e-05	0.000474	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—SMO—bone cancer	2.52e-05	0.000468	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—GSTP1—bone cancer	2.51e-05	0.000466	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—GSTP1—bone cancer	2.51e-05	0.000465	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—DHFR—bone cancer	2.51e-05	0.000465	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—GNA11—bone cancer	2.34e-05	0.000434	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—ENO2—bone cancer	2.34e-05	0.000434	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—GNA11—bone cancer	2.34e-05	0.000433	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—GNA11—bone cancer	2.31e-05	0.000428	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—ATF1—bone cancer	2.17e-05	0.000403	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—DHFR—bone cancer	2.17e-05	0.000402	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—ATF1—bone cancer	2.14e-05	0.000398	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—CYP3A4—bone cancer	2.12e-05	0.000394	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—IL3—bone cancer	2.12e-05	0.000393	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—IL3—bone cancer	2.09e-05	0.000388	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—GNA11—bone cancer	2.03e-05	0.000376	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—ENO2—bone cancer	1.92e-05	0.000356	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—ENO2—bone cancer	1.9e-05	0.000353	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—CYP3A4—bone cancer	1.84e-05	0.000341	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.83e-05	0.000339	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—GSTP1—bone cancer	1.82e-05	0.000337	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—TGFBR2—bone cancer	1.81e-05	0.000336	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—TGFBR2—bone cancer	1.79e-05	0.000332	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—DHFR—bone cancer	1.78e-05	0.00033	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—DHFR—bone cancer	1.77e-05	0.000328	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—IGF1R—bone cancer	1.71e-05	0.000316	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—IGF1R—bone cancer	1.68e-05	0.000312	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—GNA11—bone cancer	1.67e-05	0.000309	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—GNA11—bone cancer	1.65e-05	0.000306	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—GSTP1—bone cancer	1.57e-05	0.000292	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.51e-05	0.00028	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—CYP3A4—bone cancer	1.5e-05	0.000278	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.49e-05	0.000276	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—PTGS2—bone cancer	1.3e-05	0.000241	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—PTGS2—bone cancer	1.3e-05	0.000241	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—GSTP1—bone cancer	1.29e-05	0.000239	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—GSTP1—bone cancer	1.28e-05	0.000237	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—ENO2—bone cancer	1.26e-05	0.000233	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—KIT—bone cancer	1.24e-05	0.000229	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—KIT—bone cancer	1.22e-05	0.000226	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—DHFR—bone cancer	1.17e-05	0.000216	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—BRAF—bone cancer	1.16e-05	0.000215	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—BRAF—bone cancer	1.15e-05	0.000213	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—EGFR—bone cancer	1.13e-05	0.000209	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—EGFR—bone cancer	1.11e-05	0.000206	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—GNA11—bone cancer	1.09e-05	0.000202	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—MDM2—bone cancer	9.74e-06	0.000181	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—MDM2—bone cancer	9.61e-06	0.000178	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—PTGS2—bone cancer	9.41e-06	0.000174	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—JUN—bone cancer	8.47e-06	0.000157	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—GSTP1—bone cancer	8.45e-06	0.000157	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—JUN—bone cancer	8.36e-06	0.000155	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—MMP9—bone cancer	8.24e-06	0.000153	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—PTGS2—bone cancer	8.15e-06	0.000151	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—MMP9—bone cancer	8.13e-06	0.000151	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—PTGS2—bone cancer	6.69e-06	0.000124	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—EGFR—bone cancer	6.66e-06	0.000123	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—PTGS2—bone cancer	6.63e-06	0.000123	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—EGFR—bone cancer	6.57e-06	0.000122	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—TP53—bone cancer	5.59e-06	0.000104	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—TP53—bone cancer	5.52e-06	0.000102	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—PTGS2—bone cancer	4.38e-06	8.11e-05	CbGpPWpGaD
